Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
38.23
0.00 (0.00%)
Mar 9, 2026, 3:54 PM EDT - Market open
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 594 employees as of December 31, 2025. The number of employees increased by 157 or 35.93% compared to the previous year.
Employees
594
Change (1Y)
157
Growth (1Y)
35.93%
Revenue / Employee
$12,956
Profits / Employee
-$783,362
Market Cap
4.00B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| ACADIA Pharmaceuticals | 798 |
| Corcept Therapeutics | 730 |
| ADMA Biologics | 685 |
| Amicus Therapeutics | 511 |
| TG Therapeutics | 399 |
| Xenon Pharmaceuticals | 370 |
| Structure Therapeutics | 220 |
CRNX News
- 10 days ago - Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March - GlobeNewsWire
- 5 weeks ago - Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 6 weeks ago - Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH) - GlobeNewsWire
- 7 weeks ago - Crinetics Pharmaceuticals, Inc. (CRNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Crinetics Pharmaceuticals Announces January 2026 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock - GlobeNewsWire